The QualityStocks Daily Friday, September 28th, 2018

Today's Top 3 StockMarketWatch

StockMarketWatch (SKYS) +47.39%

QualityStocks (ASCK) +47.25%

QualityStocks (IGC) +40.22%

The QualityStocks Daily Stock List

Legacy Education Alliance, Inc. (LEAI)

Fortune Stock Alerts, RedChip, Marketbeat, DSR News, PHUB News, Stock Commander, and PennyPickAlerts reported earlier on Legacy Education Alliance, Inc. (LEAI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Legacy Education Alliance, Inc.  is a top global provider of practical, high-quality, and value-based educational training. This training is on the topics of personal finance, entrepreneurship, real estate, and financial markets investing strategies and techniques. The Company’s commitment is to providing quality financial education. Legacy Educational Alliance has headquarters in the United States, Canada, and the United Kingdom. The Company’s U.S. office is in Cape Coral, Florida.

Legacy Educational Alliance provides its training through an array of brands. These include Trade Up Investor Education™; Rich Dad® Education; Rich Dad® Stock Education; Making Money from Property with Martin Roberts™; Brick Buy Brick™; Building Wealth; Robbie Fowler Property Academy™; Women in Wealth™; and The Independent Woman™.

The Trade Up Investor Education™ brand underwent development in partnership with Investor's Business Daily®. Students’ are provided educational training designed to help them build their knowledge of stock and options trading. The Brick Buy Brick™ brand introduces its students to the tools and strategies utilized by successful investors to become financially free through real estate investing.

The Making Money from Property with Martin Roberts™ brand provides a property-based curriculum focused on how and why to buy property at auction. The Rich Dad® Stock Education training brand helps its students become astute investors who understand how to create winning trades and potential profits in any market condition.

The design of Robbie Fowler Property Academy™ is to teach investment strategies people can use to obtain a clear path towards long-term wealth. The Independent Woman™ is a leader in the effort to provide educational training, seminars, and services designed to help women build their financial intelligence.

Rich Dad® Education provides students with wide-ranging instruction and mentoring in real estate and financial instruments training in the U.S., Canada, and the United Kingdom. The Women In Wealth™ brand seeks to empower women with a strong financial education and help them in discovering the power of real estate investing to create cash flow and build financial independence.

Legacy Education Alliance has entered into an agreement with Get Motivated Events, LLC. The Company will market its Legacy Education™ branded real estate and paper assets training programs at Get Motivated! large stage business seminars produced by Get Motivated Events. Get Motivated! Business Seminars provide attendees the opportunity to hear from top figures in sales and marketing, negotiation, personal development, motivation, and more.

Last month, Legacy Education Alliance announced it entered into an agreement to join forces with kathy ireland® Worldwide (kiWW®) to promote their respective brands. With this agreement, Kathy Ireland®, fashion model, businessperson and entrepreneur, will act as Brand Ambassador promoting Legacy Education Alliance’s world class set of real estate and financial markets education products and services in alignment with Ms. Ireland's message of entrepreneurship and social responsibility.

Recently, Legacy Education Alliance announced that it closed on two residential properties in the United Kingdom as part of its strategy of building its business, real estate investment and development portfolio. The Company has established separate subsidiaries in the United Kingdom and the United States to concentrate exclusively on its real estate investment and development activities.

Legacy Education Alliance, Inc. (LEAI), closed Friday's trading session at $0.30, up 3.45%, on 25,304 volume with 5 trades. The average volume for the last 3 months is 7,673 and the stock's 52-week low/high is $0.231/$0.60.

chart

REGI U.S., Inc. (RGUS)

Zacks, Morningstar, Marketwired, The Street, MarketWatch, Barchart, OTC Markets and Stockhouse reported earlier on REGI U.S., Inc. (RGUS), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

REGI U.S., Inc., by way of its subsidiary, RadMax Technologies, Inc., engages in the design and development of axial vane-type rotary engines, known as the RadMax rotary technology, used in the design of engines, compressors, and pumps. RadMax Technologies is developing for commercialization numerous improved axial vane type rotary devices using its Patented RadMax™ Rotary Technology. REGI U.S. is based in Spokane, Washington.

The RadMax™ Rotary Technology allows for leading-edge designs of lightweight and high efficiency engines, compressors, pumps, and other devices. One current prototype is The RadMax™ engine. It has only two unique moving parts, the vanes (up to 12) and the rotor, in comparison to the 40 moving parts in a basic four-cylinder piston engine.

The Company’s aim is to license RadMax technology and/or participate in joint ventures (JVs) to manufacture RadMax products for specific applications. Market segments that could benefit from RadMax technology include (but are not limited to) transportation, aerospace, air conditioning and refrigeration, oil and gas production and distribution, power generation, marine, and military markets.

The Board of REGI U.S. and RadMax Technologies announced this past February that a provisional patent application was filed with the U.S. Patent and Trademark Office (USPTO) for the use of RadMax two-phase compressors and expanders to increase the efficiency of Rankine cycle steam electricity generation plants.

Also, in March, The Board of Directors of REGI U.S and RadMax Technologies announced that a provisional patent application was filed with the USPTO for the use of RadMax two-phase compressors and expanders to increase the efficiency of air conditioning and refrigeration cycles.

Earlier in July, The Board of Directors of Regi U.S. and its wholly-owned subsidiary, RadMax Technologies announced the achievement of a significant milestone in the development of the RadMax sliding axial vane gas expander. Ongoing development and testing of the gas expander prototypes have demonstrated overall efficiencies more than 70 percent, a major technical milestone.

The expectation is that future development and testing will further increase efficiencies, into the mid-80 percent range through using more advanced bearings, coatings, and other friction reducing technologies. In addition, testing has shown the device’s power curve as similar to other positive displacement engines and is characterized by a broad peak with high torque.

REGI U.S., Inc. (RGUS), closed Friday's trading session at $0.075, up 11.11%, on 2,000 volume with 1 trade. The average volume for the last 3 months is 15,739 and the stock's 52-week low/high is $0.0515/$0.30.

chart

U.S. Stem Cell, Inc. (USRM)

InvestorsHub, MarketWatch, TradingView, and Money Morning reported on U.S. Stem Cell, Inc. (USRM), and today we report on the Company, here at the QualityStocks Daily Newsletter.

U.S. Stem Cell, Inc. is a developing business in the regenerative medicine/cellular therapy industry. The Company is a developer of novel autologous cell therapies, and a provider of physician-based stem cell therapies to human and animal patients. U.S. Stem Cell is based in Sunrise, Florida. The Company formerly went by the name Bioheart, Inc. It changed its name to U.S. Stem Cell, Inc. in October of 2015.

The Company has three operating divisions: US Stem Cell Training, Vetbiologics, and US Stem Cell Clinic. U.S. Stem Cell is a leader in the development of proprietary, physician-based stem cell therapies and novel regenerative medicine solutions. Its concentration is on the discovery, development, and commercialization of cell-based therapeutics that prevent, treat, or cure disease through repairing and replacing damaged or aged tissue, cells and organs and restoring their normal function.

U.S. Stem Cell’s business includes the development of proprietary cell therapy products and revenue generating physician and patient based regenerative medicine/cell therapy training services. In addition, the Company’s business includes cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic.

U.S. Stem Cell’s lead product candidate is MyoCell®. This is a muscle stem cell therapy intended to improve cardiac function months or even years after a patient has suffered severe heart damage due to a heart attack.

MyoCell SDF-1 has received approval from the Food and Drug Administration (FDA) to commence human clinical trials. The intention of MyoCell SDF-1 is to be an improvement to MyoCell.

U.S. Stem Cell has developed a strategic alliance with Advanced Stem Cell Rx (ASC). This includes the development of autologous stem cell treatment centers across the United States. ASC is a U.S. based provider of regenerative medicine programs.

U.S. Stem Cell announced in January 2018 that it reached an important milestone of 10,000 kit sales of its proprietary Adipocell™ product. This is a direct result of its relationships with 287 clinics in the United States and 700-plus physicians worldwide offering the Company’s proprietary stem cell products and services.

Last month, U.S. Stem Cell announced Renewing Our Heroes - a charitable health initiative created to provide first responders and other civil service personnel with access to alternative medical care they would otherwise be unable to obtain - will now offer the Company’s stem cell procedures and protocols to its recipients following injuries and conditions that occur in the line of duty.

Mr. Mike Tomas, U.S. Stem Cell’s President and Chief Executive Officer, said, "Expansion of our stem cell protocol into the line of service for our first responders means we are starting to reach more and more Americans who otherwise would never have access to this incredible regenerative therapy. It is an honor for our organization to know the true heroes of our country can now have access to this standard of care."

U.S. Stem Cell, Inc. (USRM), closed Friday's trading session at $0.0265, up 5.58%, on 311,247 volume with 28 trades. The average volume for the last 3 months is 1,335,298 and the stock's 52-week low/high is $0.0194/$0.0879.

chart

Galaxy Gaming, Inc. (GLXZ)

TaglichBrothers, The Green Baron, FeedBlitz, Red Chip, SmallCapVoice, Marketbeat, and Stock Profile reported earlier on Galaxy Gaming, Inc. (GLXZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Galaxy Gaming, Inc. is the world's largest independent developer, manufacturer, and distributor of casino table games and enhanced systems. The Company develops, manufactures, and distributes unique proprietary table games, state-of-the-art electronic wagering platforms, and enhanced bonusing systems to land-based, riverboat, cruise ships, and online casinos around the world. Galaxy Gaming has its corporate headquarters in Las Vegas, Nevada.

Galaxy Gaming has an installed base of its products on thousands of gaming tables located in hundreds of casinos. The Company sells its products chiefly through its internal sales force, to casinos throughout North America, the Caribbean, the British Isles, Europe, and Africa. Moreover, Galaxy Gaming sells its products to cruise ships and internet gaming sites globally.

The Company is the exclusive provider of SpectrumVision. This is a proprietary technology used to detect invisible markings on playing cards.

Additionally, Galaxy Gaming is expanding its international footprint by way of its partnership with WPT Enterprises, Inc. WPT Enterprises is the owner of the World Poker Tour.

Furthermore, through its iGaming partner, Progressive Games Marketing Ltd., Galaxy Gaming licenses its proprietary table games to the online gaming industry. The Company’s games can be played online at FeelTheRush.com.

In May, Galaxy Gaming announced its results for the quarter ended March 31, 2018. For Q1 2018 in comparison to Q1 2017, the Company’s Revenue increased 25 percent to $4,361K. Revenue increased 20 percent to $4,154K, excluding the effect of accounting change.

Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased 28 percent to $1,559K. Pre-tax income grew 184 percent to $682K, and Net Income grew 231 percent to $537K.

Recently, Galaxy Gaming announced the acquisition of a portfolio of intellectual property (IP) developed by students participating in UNLV’s Center for Gaming Innovation. This portfolio comprises an array of table games and table-game apparatus that was further prepared for commercialization and sold to Galaxy Gaming by Big Bet Gaming, LLC.

Mr. Mark L. Yoseloff, Ph.D., Executive Director of the Center of Gaming Innovation at UNLV, leads a semester-long course connecting students with established gaming leaders who serve as guest lecturers and mentors. The classes concentrate on gaming commercialization concepts and technology, the patent process, marketing, and successful business strategies.

Galaxy Gaming, Inc. (GLXZ), closed Friday's trading session at $1.29, up 7.50%, on 12,450 volume with 9 trades. The average volume for the last 3 months is 14,240 and the stock's 52-week low/high is $0.509/$1.47.

chart

Jones Soda Co. (JSDA)

Actual Gains, Wealthpire, Investor Update, SmallCapVoice, PennyStockRumors, PricelessPennyStocks, SmarTrend Newsletters, TopStockAnalysts, Stock Analyzer, SuperNova Elite, and Dividend Opportunities reported earlier on Jones Soda Co. (JSDA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Jones Soda Co. is a leader in the premium soda category. The Company has a reputation for its innovative flavors and branding. Jones Soda markets and distributes premium beverages under the Jones® Soda, Jones Zilch®, Jones Stripped™ and Lemoncocco™ brands. Jones Soda has its headquarters in Seattle, Washington.

The Company sells throughout North America in glass bottles, cans and on fountain via traditional beverage outlets, restaurants, and alternative accounts.

Jones Soda is made with pure cane sugar. The Company’s diverse product line includes pure cane sugar soda, zero-calorie soda, and an all-naturally sweetened sparkling beverage with only 30 calories and 8 grams of sugar. Additionally, Jones Soda sells Jones Gear (clothing items) and Jones Candy.

Jones Soda has its natural soda line - Jones Stripped. Natural Jones Soda launched in California during 2013 to meet the burgeoning demand for healthier beverage options and to expand the Jones product portfolio. Jones Stripped is sweetened with a blend of natural sweeteners. These include pure cane sugar, organic agave syrup, and stevia.

7-Eleven, Inc. and Jones Soda have partnered and created 7-Select® brand premium sodas crafted by Jones. This is the first premium carbonated beverage in the 7-Select private brand line-up. Each 7-Select premium soda is made with natural flavors, lightly sweetened with cane sugar, and ranges from only 180 to 195 calories per 20-ounce bottle. In addition, this brand includes 75 mg. of caffeine in each serving.

Jones Beverages International is a subsidiary of Jones Soda. This subsidiary has its premium non-carbonated blended beverage brand named Lemoncocco™. This product is flavored with the extracts of Sicilian lemons and a bit of coconut cream. Lemoncocco™ is a natural beverage, lightly sweetened with a little cane sugar. It is 90 calories per 12 ounce serving. Additionally, it is dairy free and gluten free.

Jones Soda and 7-Eleven, Inc. are expanding the number of stores carrying regional Big Gulp® flavors created by the Company. Customers at greater than 1,000 7-Eleven® stores in northern California and Canada now can enjoy exclusive Jones® flavors on the Big Gulp fountain.

Previously, these proprietary beverages were only available at participating 7-Eleven stores in Oregon and Washington State. Flavors will vary according to region. Furthermore, 7-Eleven and Jones Soda will release new limited time 7-Select flavors throughout this year. 7 Eleven is the largest chain in the convenience-retailing industry. It operates, franchises and/or licenses more than 66,000 stores in 17 countries.

Jones Soda Co. (JSDA), closed Friday's trading session at $0.4106, up 3.95%, on 72,451 volume with 31 trades. The average volume for the last 3 months is 86,826 and the stock's 52-week low/high is $0.25/$0.479.

chart

Liberty One Lithium Corp. (LRTTF)

ProcativeInvestors, OTC Markets, 4 Traders, and MarketWatch reported on Liberty One Lithium Corp. (LRTTF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Liberty One Lithium Corp. is a developing exploration company listed on the OTC Markets’ OTCQB. It centers on the acquisition and development of high grade lithium brine deposits. The Company sees lithium as an opportunity to participate in the diversification and continued growth (and protection) of a strong global energy policy.

Liberty One Lithium is based in Vancouver, British Columbia. The Company was previously known as Peace River Capital Corp. It changed its corporate name to Liberty One Lithium Corp. in December of 2016.

The Company’s initial prospects are in Argentina’s “Lithium Triangle” and Utah’s Paradox Basin. They are in historic sources of high grade lithium-bearing brines. Historic resource indicates potential to produce large volumes of brine on-site.

In Utah, Liberty One Lithium’s North Paradox property consists of 233 placer claims encompassing 4,480 acres located upon the Paradox Basin in Grand County, Utah, 15 kilometers west of the town of Moab, in southeastern Utah. The presence of the adjacent Cane Creek mine that has been producing potash for 45 years uses a similar process as envisaged for mining lithium at Liberty One indicates that this form of production should be feasible.

In Argentina, the Company’s Pocitos West prospect consists of over 39,000 acres (15,857 Ha) in the middle of the well-known lithium triangle. It is in the Pocitos Salar, Los Andes Department, Western Salta Province, Argentina. This Project is in the middle of all the present lithium Projects of the region.

Liberty One Lithium has a mineral option and joint venture (JV) agreement with Millennial Lithium Corp. (Vancouver, British Columbia). The agreement grants Liberty One Lithium the sole and exclusive right and option to acquire up to an 80 percent undivided beneficial right, title, and interest in the Pocitos West project in Argentina.

Liberty One Lithium previously affirmed 2018 plans to begin an evaluation of its promising “North Paradox” property within the Paradox Basin in Grand County, Utah. Log data at the Utah Geological Survey library indicates the area appears rich with supersaturated brines. Also, nearby long-term mine operations effectively demonstrate the climatic efficacy for traditional evaporative production processes.

Liberty One Lithium Corp. (LRTTF), closed Friday's trading session at $0.1336, up 1.21%, on 42,921 volume with 30 trades. The average volume for the last 3 months is 122,279 and the stock's 52-week low/high is $0.10/$1.95.

chart

Mobivity Holdings Corp. (MFON)

NetworkNewsWire, Equity Clock, Street Insider, OTC Markets, Investors Hub, Barchart, Stockhouse, and Zacks reported earlier on Mobivity Holdings Corp. (MFON), and today we highlight the Company, here at the QualityStocks Daily Newsletter

Mobivity Holdings Corp. provides a platform for intelligent and personalized marketing in the real world. It takes advantage of detailed purchase data and communications platforms to improve business results through understanding, predicting, and influencing consumer behavior. The Company helps restaurant and retail brands increase their business through boosting customer frequency, engagement, as well as spend. OTCQB-listed, Mobivity Holdings is headquartered in Arizona.

Mobivity drives better actions and informs decisions through connecting Point of Sale (POS) outcomes to the events and influences that caused them. Its platform comprises software for phones, tablets, PCs, and POS (Point-of-Sale) systems.

These enable resellers, brands, and enterprises to market their products and services to consumers via text messages sent directly to consumers through mobile phones, mobile smartphone applications, and printed receipt content.

The Company is the maker of the award-winning re•currency platform. This platform increases customer visits and spend in restaurants, retail, and personal care brands. The re•currency set of products increases customer engagement and frequency through capturing detailed POS transaction records, analyzing customer habits, and motivating customers and employees via data-driven messaging applications and rewards.

Mobivity’s platform is used to increase participation in one-to-one marketing and customer engagement by way of mobile first interactions. The Company’s products assist brands in aggressively interacting with a following of consumers who can help a client increase top-line sales through suggestive selling.

Mobivity Holdings is pioneering a blockchain-powered platform for commerce and customer communication with brands. The Company has made announcements regarding the development of its platform to enable currency-based customer rewards programs and the precise tracking of offer and coupon redemptions.

This past May, Mobivity Holdings announced financial results for Q1 ended March 31, 2018. Under the new accounting standard, ASC606, new customer gains mainly contributed to growing Total Revenue to $3.7 million. This represents a 75 percent increase over Q1 2017 Revenue of $2.1 million.
Total minimum contract values increased to over $21 million. Gross Margins grew to 79 percent under the new ASC606 accounting standard.

Mobivity Holdings Corp. (MFON), closed Friday's trading session at $1.55, up 6.90%, on 72,666 volume with 17 trades. The average volume for the last 3 months is 20,914 and the stock's 52-week low/high is $0.762/$1.799.

chart

Amarantus Bioscience Holdings, Inc. (AMBS)

Stockopedia, Nasdaq.com, Stockhouse, 4-Traders, Zacks, Streetwise Reports, InvestorsHub, and Insider Financial reported on Amarantus Bioscience Holdings, Inc. (AMBS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Formed in 2008, Amarantus Bioscience Holdings, Inc. is JLABS-alumnus biotechnology holding company. It is developing first-in-class orphan neurologic, regenerative medicine and ophthalmic therapies through its subsidiaries. The Company’s wholly-owned subsidiaries include Elto Pharma, Inc; Cutanogen Corporation, and MANF Therapeutics. Amarantus Bioscience Holdings is based in New York, New York.

Amarantus Bioscience also owns about 79.25 million shares of Avant Diagnostics, Inc. (AVDX) via the sale of its wholly-owned subsidiary Amarantus Diagnostics, Inc. that took place in May 2016.

Amarantus Bioscience is centering on developing therapeutic products with the potential for orphan drug designation in the areas of neurology, psychiatry, ophthalmology and regenerative medicine, and diagnostics in neurology. The Company’s lead therapeutic program is eltoprazine. This is a Phase 2b-ready small molecule indicated for the treatment of Levodopa-induced dyskinesia - one of the most difficult problems facing patients with Parkinson’s disease.

Elto Pharma has development rights to eltoprazine. In addition, eltoprazine is undergoing evaluation for the treatment of adult attention deficit hyperactivity disorder (ADHD) and Alzheimer’s aggression.

The Company’s diagnostics division is Amarantus Diagnostics. Its lead diagnostic product is LymPro Test®. This is a blood-based assay to diagnose Alzheimer’s disease. LymPro Test® is approved for investigational use only to be used in biotechnology and pharmaceutical clinical trials.

Amarantus Diagnostics is also developing MSPrecise®. This is a proprietary, next-generation DNA sequencing (NGS) assay for the identification of patients with relapsing-remitting multiple sclerosis (RRMS) at first clinical presentation.

Amarantus Bioscience’s subsidiary MANF Therapeutics owns key intellectual property (IP) rights and licenses from many prominent universities related to the development of the therapeutic protein called mesencephalic astrocyte-derived neurotrophic factor (MANF). MANF Therapeutics is developing MANF-based products as treatments for brain and ophthalmic disorders.

Also, Amarantus Bioscience acquired the rights to the Engineered Skin Substitute program. This is a regenerative medicine-based approach for treating severe burns with full-thickness autologous skin grown in tissue culture that is being pursued by subsidiary Cutanogen Corporation.

Recently, Amarantus Bioscience announced that based upon its review of the clinical data from a German-based clinical study led by Leipzig University's Dr. Thomas Arendt, it exercised its Exclusive Option with Leipzig to negotiate license rights to Alzheimer's blood diagnostic "LymPro Test 2.0," that compares traditional LymPro Test results with those of amyloid PET imaging for the diagnosis of Alzheimer's disease.

Amarantus Bioscience and Leipzig University agreed to broaden the scope of license negotiations to include additional key markers collected during the clinical study. This includes CSF-tau.

Amarantus Bioscience recently received an independent third-party valuation report that valued the Parkinson's disease levodopa-induced dyskinesia (PD-LID) indication for Eltoprazine in the United States and Europe at $316 million. Company management has outlined two distinct paths for Elto Pharma to get as much value for the Eltoprazine asset for Amarantus Bioscience as possible.

One path is standalone private funding followed by a U.S. or Hong Kong-based IPO. The second path may be a business combination with an established clinical-stage biopharmaceutical company with strong management and a first-rate pipeline in which Amarantus Bioscience could become a major shareholder. Amarantus Bioscience expects to make a final determination on the capital formation plan for Elto Pharma this summer.

Amarantus Bioscience Holdings, Inc. (AMBS), closed Friday's trading session at $0.0338, up 4.55%, on 253,036 volume with 25 trades. The average volume for the last 3 months is 436,890 and the stock's 52-week low/high is $0.0099/$0.2085.

chart

Auxly Cannabis Group, Inc. (CBWTF)

MicroSmallCap, Zacks, All Penny Stocks, OTC Markets, Investor Place, MarketWatch, Daily Marijuana Observer, InvestorsHub, Stockhouse, Marijuana Stox, TradingView, Wallmine, 4-Traders, The National Marijuana News, Marketbeat, The Street, Marijuana Index, and Pot Network reported on Auxly Cannabis Group, Inc. (CBWTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Auxly Cannabis Group, Inc. operates as a cannabis streaming company. Its mandate is to facilitate growth for its partners through providing them with financial support and sharing the Company’s collective industry experience. Auxly Cannabis invests and supports a broad array of cannabis cultivation companies.

Auxly Cannabis is headquartered in Vancouver, British Columbia. The Company previously went by the name Cannabis Wheaton Income Corp. It changed its name to Auxly Cannabis Group, Inc. last month.

The Company has created a foundational platform covering the whole cannabis value-chain, minimizing risk while at the same time maximizing exposure to multiple, geographically-diverse cannabis companies via a single source.

Auxly Cannabis team has a wealth of knowledge from cultivation, regulatory, construction, retail, branding, finance and technology. The Company is using the stream, or streaming model, to finance cannabis companies.

Auxly Cannabis’ provides financial support for cannabis facility expansions, operations, and initial construction. It does so in exchange for minority equity interests and a portion of the cultivation production. Auxly Cannabis partners maintain their brand autonomy. In addition, they obtain access to better scaling flexibility.

In November 2017, Auxly Cannabis announced the closing of the acquisition of all the issued and outstanding shares of RockGarden Medicinals (2014), Inc. pursuant to the terms of a definitive share purchase agreement dated October 31, 2017. RockGarden was granted a cultivation license on August 25, 2017. RockGarden is a privately owned licensed producer of cannabis pursuant to the ACMPR.

This past February, Auxly Cannabis announced that it entered into a joint venture (JV) with Mr. Peter Quiring, one of Canada’s largest greenhouse builders and operators, by way of a newly formed subsidiary (GreenhouseCo), to develop, build and operate a state-of-the-art purpose-built greenhouse for cannabis cultivation in Leamington, Ontario.  Mr. Quiring will act as Chief Executive Officer of GreenhouseCo.

Pursuant to the agreement, Mr. Quiring, through South Essex Fabricating, will be responsible for the design, construction and operation of the Facility.  The Company will be responsible for funding the project and assisting JVCo in obtaining its ACMPR license for the cultivation and sale of cannabis through providing JVCo with all the resources and expertise necessary to attain the License.

Auxly Cannabis Group, Inc. (CBWTF), closed Friday's trading session at $0.8879, up 7.90%, on 1,035,782 volume with 818 trades. The average volume for the last 3 months is 1,604,875 and the stock's 52-week low/high is $0.56/$2.70.

chart

Drone USA, Inc. (DRUS)

Stock News Now, Stock Daily Review, OTC Markets, InvestorsHub, 4-Traders, and Stockhouse reported on Drone USA, Inc. (DRUS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Drone USA, Inc. is a developer, manufacturer, and distributor of low altitude drones and related technologies. The Company’s primary target markets include U.S. police, firemen, and the U.S. Government. Drone USA designs and builds high quality drones, training, insurance, replacement parts and anything a customer requires to ensure their missions are successful. All the Company’s products will be manufactured and assembled in the United States. Drone USA is headquartered in West Haven, Connecticut.

Drone USA services include Real Estate Photography for Advertisement; Utility Inspection; and Construction Inspection & Photo/Video Marketing. In addition, Services include Precision Agriculture; Search & Rescue Assistance; and Fire Hot Spot Location. All of the Company’s drones operate with closed encrypted software. This is for national security purposes.

Founded in 1990, Howco Distributing Co. (Vancouver, Washington) is a subsidiary of Drone USA. Howco Distributing is the Company’s manufacturing supply chain segment. Howco Distributing is a premier supplier of spare and replacement parts to the United States Federal Government and commercial customers globally. Howco is an authorized provider for hundreds of manufacturers and original equipment manufacturers (OEMs).

Howco Distributing's services encompass bid solicitation, contract management, packaging and logistics for construction, transportation, mining and heavy equipment spare and replacement parts to customers worldwide using a wide variety of supply chain solutions.

Drone USA is working on three profitable growth strategies. These are Police & U.S. Government drone sales; increasing Howco Distributing’s product line and reach; and acquiring companies that expand Drone USA’s product and customer base.

Last month, Drone USA announced a reseller partnership with Thermaxx LLC. Thermaxx specializes in energy efficient insulation jackets. Thermaxx's solutions enable clients to save energy with user-friendly, removable insulation jackets when traditional stay-in-place insulation is not practical, particularly for mechanical systems, pipes, valves and heavy equipment.

This week, Drone USA announced subsidiary Howco Distributing was awarded a three year 1.7-million-dollar contract from the US Government's Defense Logistics Agency with an option to extend for two more years for trailer support components.

Drone USA, Inc. (DRUS), closed Friday's trading session at $0.0042, up 5.00%, on 11,551,349 volume with 118 trades. The average volume for the last 3 months is 59,055,768 and the stock's 52-week low/high is $0.0038/$0.2199.

chart

Sustainable Projects Group, Inc. (SPGX)

OTC Markets, Market Exclusive, MarketWatch, and OilandGas360 reported on Sustainable Projects Group, Inc. (SPGX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sustainable Projects Group, Inc. is a member of SP Group. Sustainable Projects is positioned to become a world leading natural resources holding and development enterprise via value-based investments and collaborative partnerships with worldwide leaders across the natural resources sector. SP Group has initiated its goals through pursuing investment and partnerships with some of the most diversified and integrated companies available on the market.

Sustainable Projects Group is headquartered in Naples, Florida. The Company lists on the OTC Markets Group’s OTCQB.

The Company is to invest into undervalued international companies through direct investment. Additionally, it is negotiating investment and collaboration agreements with different global leaders throughout the natural resource industry.

SP Group’s dedication is to negotiating working interests (WIs) in a wide variety of natural resource projects around the world. It uses the local knowledge and expertise of companies that operate its interests. Therefore, it benefits as non-operators from low-risk opportunities to provide a steady stream of resources to the worldwide market.

SP Group chooses its investments and partnerships only from well established companies with a proven record of accomplishment and that bring strong project experience to the Company. Currently, it is invested in a range of natural resources projects beyond its initial focus on oil and gas. It has plans to considerably add to the portfolio over the coming years.

In December of 2017, Sustainable Projects Group announced the acquisition of myfactor.io AG. This is a business development enterprise headquartered in Liechtenstein.

Sustainable Projects Group is gaining direct access to a company with the experience and infrastructure to develop SME's and issue bonds. This will allow Sustainable Projects Group to further extend the range of consulting and business development expertise represented within the Company. As part of its growth strategy for SME's, myfactor.io can place bonds in US Dollars, Euros and Swiss Francs.

In February of this year, Sustainable Projects Group announced the acquisition of a 10 percent stake in Falcon Projects AG.  Falcon specializes in bridge financing and refinancing solutions in the construction and project development industry. With the acquisition, Sustainable Projects Group continues to widen its network of investments and partners in different industries.

Recently, Sustainable Projects Group announced that Stefan Muehlbauer, who has previously served as the Company's Chief Financial Officer (CFO) was appointed to Chief Executive Officer (CEO). Christian Winzenried who has served as the Company's CEO since 2017 was named CFO.

Sustainable Projects Group, Inc. (SPGX), closed Friday's trading session at $3.30, up 6.45%, on 2,600 volume with 6 trades. The average volume for the last 3 months is 801 and the stock's 52-week low/high is $3.00/$4.50.

chart

Terra Tech Corp. (TRTC)

Stock of the Week, Stockhouse, Epic Stock Picks, Street Register and Penny Stock Tweets reported on Terra Tech Corp. (TRTC), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Terra Tech Corp. is a vertically integrated cannabis-focused agriculture company. It operates through numerous subsidiary businesses. These include Blüm, IVXX Inc., Edible Garden, and MediFarm LLC. Terra Tech’s commitment is to cultivate and provide the highest quality medical cannabis and other agricultural products. Listed on the OTCQX, Terra Tech is based in Irvine, California.

Terra Tech is integrating the best of the natural world with technology to create sustainable solutions for medical cannabis production, extraction and distribution, plant science research and development, food production, and Closed Environment Agriculture (CEA).

IVXX, Inc. is a wholly-owned subsidiary of Terra Tech. IVXX produces cannabis-extracted products for regulated medical cannabis dispensaries throughout California and medical and adult-use dispensaries in the State of Nevada.

Terra Tech has its wholly-owned subsidiary Edible Garden. It cultivates a premier brand of local and sustainably grown hydroponic produce. It sells via major grocery stores. In New Jersey, construction is taking place for a major new pack house to distribute salads and leafy greens for Edible Garden.

Terra Tech's MediFarm LLC subsidiaries focus on medical and adult-use cannabis cultivation. Additionally, MediFarm subsidiaries focus on permitting businesses throughout Nevada.

Blüm offers a broad selection of cannabis products. These include flowers, concentrates, and edibles through its Oakland, California and many Nevada locations.

Terra Tech’s capital expenditures for this calendar year will be directed toward the build out of its cultivation, extraction, and retail infrastructure in California, Nevada and New Jersey. In Oakland, Terra Tech is building a 13,000-square-foot cultivation facility. This facility will have the capacity to produce up to one metric ton, or 2,000 pounds, of cannabis per year.

Terra Tech has completed construction in Nevada of a new 30,000 square foot cannabis cultivation facility in Sparks and a 15,000 square foot cannabis extraction facility in Reno through agreements with NuLeaf. The Company is awaiting final State approval to start IVXX production at the Reno facility.

In June, Terra Tech announced that it began cultivation at its new Sparks facility, following approval from the State of Nevada. The team has successfully started cultivation of its first cannabis crop, planting the first seeds in early June. The Company expects to distribute and sell cannabis grown at the Sparks facility from its first harvest throughout Nevada by Q4 2018.

Terra Tech Corp. (TRTC), closed Friday's trading session at $2.08, up 0.97%, on 1,178,901 volume with 1,411 trades. The average volume for the last 3 months is 1,076,595 and the stock's 52-week low/high is $1.52/$9.375.

chart

Helix TCS, Inc. (HLIX)

The Stock Rover, Market Exclusive, Green Market Report, Stock Daily Review, The Daly Marijuana Observer, Marketwired, Simply Wall St, Business Insider, and The Street reported on Helix TCS, Inc. (HLIX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Helix TCS, Inc. is a provider of integrated operating environment solutions for the legal cannabis Industry. It has acquired Cannabase, which is the oldest and largest wholesale platform in the cannabis industry. Helix TCS’ mission is to provide clients with the most powerful and inventive integrated operating environments in the market. This is to help clients better manage and lessen risk while they concentrate on their core business.

Helix TCS is based in Greenwood Village, Colorado. The Company lists on the OTC Markets’ OTCQB. The Company’s team consists of former military, law enforcement, and technology professionals. Helix TCS’ services include Technology, Compliance, and Security. It offers a technology platform that allows clients to manage inventory and supply costs via Cannabase.

Concerning Compliance, Helix TCS has a wide spectrum of compliance services for companies in the Cannabis Industry. This safeguards clients’ ability to operate while increasing their access to services.

Pertaining to Security, the Company offers Transport, Armed and Unarmed Guarding, Training, Investigation, as well as Special Services. Security is its flagship service offering.

Helix TCS acquired Security Grade Protective Services, Ltd. in 2017.  Security Grade operates as a wholly-owned subsidiary of Helix TCS. Security Grade is a Denver, Colorado-based security firm. It provides a range of custom, full-service security solutions to cannabis business customers.

Helix TCS announced this past March that it signed a merger agreement with Bio-Tech Medical Software, Inc. (dba BioTrackTHC).  The combined company will trade under the Helix stock symbol, HLIX, on the OTCQB.  Both companies will continue to operate independently.

On June 4, 2018, Helix TCS, in conjunction with its strategic capital partner, Rose Capital, announced the closing of its merger with Bio-Tech Medical Software, Inc. (dba BioTrackTHC). The merger closed on June 1, 2018.

Bio-Tech Medical Software, through its BioTrackTHC division, develops and licenses product traceability, inventory management, and Point-of-Sale (POS) software systems for the developing medical and recreational cannabis industry. BioTrackTHC has secured 9 government contracts. It operates in greater than 2,200 locations across 29 states, D.C., and 5 countries.

BioTrackTHC has launched its newest integration with DataOwl to deliver value-added functionalities for dispensaries. DataOwl's all-inclusive integration with BioTrackTHC enables dispensaries to increase revenues via online ordering, in-store digital menus, and behavior-based SMS text messaging. These are all driven by real-time inventory levels from the dispensary's POS to eliminate double entry.

DataOwl is exclusively integrated with BioTrackTHC. The two companies share customers in Arizona, California, Colorado, Hawaii, Montana, Nevada, New Mexico, Oregon and Washington.

Helix TCS, Inc. (HLIX), closed Friday's trading session at $1.24, up 4.20%, on 14,707 volume with 26 trades. The average volume for the last 3 months is 16,492 and the stock's 52-week low/high is $0.75/$6.00.

chart

Know Labs, Inc. (KNWN)

High Rising Stocks, VentureLine, Stockwatch, Amigo Bulls, Dividend Investor, OTC Markets, Spotlight Growth, Insider Tracking, Stockhouse, Business Wire, 4-Traders, Open Insider, Marketbeat, last10k, Stockwatch, MarketWatch, Simply Wall St, Stockopedia, Investors Hangout, TradingView, Insider Monkey, InvestorsHub, Street Insider, Wallet Investor, and YCharts reported on Know Labs, Inc. (KNWN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Know Labs, Inc. is developing a new technology platform that measures blood glucose non-invasively. The Company invented a pioneering technology called Bio-RFID, which will provide information to consumers about their health and wellness. In addition, Know Labs uses its proprietary ChromaID technology to identify unique molecular signatures in materials.

The Company previously went by the name Visualant, Incorporated. It changed its name to Know Labs, Inc. in May of this year. Know Labs lists on the OTC Markets Group’s OTCQB.

Know Labs develops technology platforms that harness light and radio waves to uncover distinctive insights about the world. Its technology directs electromagnetic energy via a substance or material to capture a unique molecular signature.

Know Labs refers to these signatures as ChromaID™ and Bio-RFID™. ChromaID and Bio- RFID are used to identify, detect, or diagnose substance markers or biomarkers, which may be invisible to the human eye.

ChromaID and Bio-RFID scanner modules can be integrated into an array of mobile or bench-top form factors. This patented and patent pending, award-winning technology makes it possible to effectively conduct analyses that could only formerly be performed by invasive and/or large and expensive lab-based tests.

In late May, Know Labs announced that Mr. Michael Grabham was appointed Chief Business Officer of the Company. Mr. Grabham is a Seattle serial entrepreneur. He has started six companies over the past 25 years. Mr. Grabham has led, as President, a number of companies from a regional telecommunications company ($14M annual sales) to a software assessment company (startup).

Last week, Know Labs released a video of the Company’s invention of a new technology to detect blood glucose non-invasively. In the video, Know Labs’ Chief Executive Officer, Mr. Phil Bosua, briefly talks about the breakthrough.

Know Labs is continually researching to expand the use of its technology into applications that will benefit everyday life. At present, Know Labs has 12 issued patents with 20 pending, covering its specialty.

Know Labs, Inc. (KNWN), closed Friday's trading session at $3.905, up 9.23%, on 2,865 volume with 10 trades. The average volume for the last 3 months is 32,937 and the stock's 52-week low/high is $0.17/$5.75.

chart

The QualityStocks Company Corner

Green Hygienics Holdings Inc. (GRYN)

The QualityStocks Daily Newsletter would like to spotlight Green Hygienics Holdings Inc. (GRYN).

Green Hygienics Holdings (OTC: GRYN), a full-scope, premium cannabis cultivation company, recently announced that it has appointed Matthew Dole and Jeff Palumbo to its management team. To view the full article, visit: http://nnw.fm/Qes7f.

Green Hygienics Holdings Inc. (GRYN) is a full-scope, premium cannabis cultivation company targeting the high-end medical and adult-use recreational market. With more than 25 years of experience in agricultural science and innovation, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company will grow by generating revenues from the sales of premium grade cannabis products, developing and licensing valuable IP, making strategic acquisitions, and creating trusted global consumer brands.

The company has integrated and is developing its own IP assets related to proprietary systems and apparatus, software, algorithms and custom-engineered hardware. This provides ultimate efficiencies in a commercially controlled cultivation environment. Utilizing the advantages of hybrid-aeroponics, Green Hygienics creates a sterile growing environment that produces consistent, high-quality product while maintaining the lowest possible carbon footprint. The company utilizes state-of-the-art, quality-controlled commercial cultivation methodology to assure production of pharmaceutical-grade cannabis at much higher yields and greatly reduced costs.

Hybrid-aeroponics produces quality cannabis faster than traditional methods since it doesn’t require natural sunlight or soil and can be operational and produce plants anywhere. Plants grown under aeroponic conditions receive water and nutrients directly to their roots via a fine mist in a controlled environment, dramatically reducing spoilage while keeping the product organic and the environment pest-free. The plants are given the exact amount of nutrients and moisture precisely when needed. Green Hygienics maintains ultimate control over every aspect of this cultivation process, which allows the company to operate with conservation of natural resources in mind. The technology that uses 90-95 percent less water and does not require the use of pesticides or fungicides.

Additionally, the company’s state-of-the-art engineered, controlled environments include electrical, mechanical and HVAC designs that meet mandatory fire and energy codes while improving energy efficiency significantly.

Through these practices, Green Hygienics is establishing itself as a leader in the advancement of science-driven cannabis cultivation systems. The company continues to develop and incubate software as well as engineer hardware to provide additional control over the commercial cultivation method. The company’s science-based approach reveals any growth anomalies before the human eye can see them. This makes it possible to monitor all facets of production, identify cultivation problems based upon scientific data, and implement immediate corrective action, if needed.

The future of commercial cannabis cultivation hinges on using science to control the growing environment in order to remain competitive and deliver a premium grade of product on a consistent basis. The company holds a competitive advantage through its ability to produce premium cannabis products at a significantly lower cost per gram than direct competitors and others in the cannabis industry.

Innovations within the sector that create efficiencies and successful brands will become highly valued. Green Hygienics and its forward-thinking management team are constantly studying the market dynamics of the cannabis industry in North America and abroad while actively pursuing possible expansion opportunities. The company is headquartered in Las Vegas, Nevada and establishing operations in San Diego, California, targeting the $5 billion California cannabis market.

Green Hygienics Holdings Inc. (GRYN), closed the day's trading session at $0.3859, up 4.13%, on 12,199 volume with 11 trades. The average volume for the last 3 months is 64,875 and the stock's 52-week low/high is $0.0099/$0.50.

Recent News

chart

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (BKKSF).

The nascent industries serving state-by-state cannabis legalization in the United States are feeling growing pains as they deal with the costs of delivering safe and quality-tested products to consumers. In this new age of plant-drug liberalization, BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) is offering hope of some ground-level security to the product pipeline, so consumers can distinguish between potentially healthful cannabis and potentially low-quality products.

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.

VERIFICATION = CERTIFICATION

BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.

SAFE CONSUMER SUPPLY

BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.

INTELLECTUAL PROPERTY RIGHTS

BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (BKKSF), closed the day's trading session at $0.2593, up 6.47%, on 21,440 volume with 15 trades. The average volume for the last 3 months is 111,364 and the stock's 52-week low/high is $0.109/$0.85.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV).

The Board of Medical Marihuana Regulation in Michigan is considering allowing provisioning centers (medical marijuana dispensaries) to make home deliveries of medical cannabis to patients who request that service. The authorities seem to have considered this matter for a while, and the provisions of the permanent regulations will smooth the operation of the medical cannabis industry. Canopy Rivers Inc. (TSX.V: RIV) can only hope that all jurisdictions do everything that they can to make it possible for patients to receive medical cannabis without leaving any loopholes that can lead to the misuse of medical marijuana.

Canopy Rivers Inc. (TSX.V: RIV) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $6.35, up 0.63%, on 1,962,793 volume with 3,753 trades. The stock's 52-week low/high is $3.188/$11.82.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

During the first half of 2018, Net Element (NASDAQ: NETE) subsidiary Netevia reportedly processed $1.62 billion in transactions, with $1.4 billion occurring in North America. To view the full article, visit: http://nnw.fm/mG30A. Also today, NetworkNewsWire released a report on the company detailing the news that Net Element subsidiary Unified Payments is launching a subscription-based payment processing service through a partnership with Payment Club, Inc. is a value-added case in point, with $7 million raised to finance related expansion plans (http://nnw.fm/eLiP8).

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $5.39, off by 0.19%, on 36,602 volume with 235 trades. The average volume for the last 3 months is 95,206 and the stock's 52-week low/high is $3.47/$33.51.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis Inc. (TSXV: VIVO, OTCQX: VVCIF) (“VIVO” or the “Company”) is pleased to announce that it has signed a multi-year agreement with national cannabis distributor, Green Hedge Education & Distribution Services Ltd. (“Green Hedge”). Green Hedge will be VIVO’s Canadian sales and distribution partner, providing full coverage to licensed cannabis wholesalers and retailers across Canada.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $1.20, up 4.50%, on 364,714 volume with 505 trades. The average volume for the last 3 months is 683,969 and the stock's 52-week low/high is $0.73/$3.29.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a drug delivery platform innovator, this morning announced the filing of a new strategic patent application. Per the update, the new provisional patent application is entitled “Lipophilic Active Agent Infused Tobacco Leaves and/or Tobacco Materials and Methods of Use Thereof” and represents Lexaria’s tenth patent family, expanding the applicability of the already-patented DehydraTECH technological process to impart benefits to tobacco leaves that may be utilized to deliver compounds that may or may not include nicotine. Notably, Lexaria intends to manage between 150 and 200 patent applications around the world within two years. To view the full press release, visit: http://nnw.fm/NlI0I.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.91, up 1.60%, on 97,734 volume with 162 trades. The average volume for the last 3 months is 204,717 and the stock's 52-week low/high is $0.322/$2.54.

Recent News

chart

Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF)

The QualityStocks Daily Newsletter would like to spotlight Phivida Holdings Inc. (PHVAF).

The concept that beverages may serve a “functional” purpose has developed within the health and wellness industry as cannabis producers examine ever-expanding options for putting the plant’s properties to use. Hemp-cultivated cannabinoid innovator Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) is pursuing the beneficial possibilities of new drink products infused with active hemp extract while marketing its existing line of Vida+ brand hemp oil extracts and capsules. Also today, NetworkNewsWire released a report detailing how the company recently launched its “Oki” product line of drinks and supplements featuring hemp extracts into the mainstream market. To view the full article, visit: http://nnw.fm/J9Syu.

Headquartered in Vancouver, Canada, with operations offices in southern California, Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) is a premium food and beverage company that develops CBD-infused functional foods, beverages and supplements poised for global distribution. All products in the Phivida label are infused with organic, hemp-derived cannabinoids into a variety of premium foods, beverages and clinical products for everyday health. Phivida is guided by a team of Fortune 500-caliber executives focused on a new strategic portfolio of products and brands, comprehensive consumer research, new product and brand development, improved visual identity and packaging design, and a strong distribution strategy.

The company’s motto – “Celebrating Health and Wellness, in Harmony™” – underscores Phivida’s mission to lead the alternative health care sector as the benchmark standard in premium CBD-infused functional beverages and tinctures. To execute this goal, Phivida is taking advantage of positive legislative developments in the United States and has defined an elevated national route-to-market strategy across the U.S. where small regional distributors will be now be replaced with large national distributors.

Management

Phivida’s management team includes president and CEO Jim Bailey, former president of Red Bull Canada and global chief marketing officer for Merrell Outdoors; Chief Marketing Officer Michael Cornwell, former chief marketing officer for Samsung New Zealand and the former director of marketing for Red Bull Canada; and Doug Campbell, former director of sales for Red Bull North America, who as Phivida’s chief commercial officer is tasked with driving new sales revenue growth.

Publicly traded on the Canadian Securities Exchange (CSE.VIDA) and recently graduated to the OTCQX Best Market in the USA (OTCQX.PHVAF), the company’s strong balance sheet carries CAD$15.7 million with no debt or loans with less than 60 million shares outstanding and the company is now well-capitalized to fun major mainstream distribution with a solid structure poised for long-term growth.

The Science

Using encapsulation technology, Phivida uses full spectrum CBD-hemp oil (rich in naturally occurring phytocannabinoids) converted into a water-soluble delivery format, which enhances delivery and absorption of the cannabinoids into the human body – up to an estimated tenfold.

Encapsulated CBD is infused into functional beverages, food and supplements containing a proprietary blend of phytonutraceuticals studied to target a range of health and wellness conditions. Phivida tests every product for microbials, heavy metals, pesticides, residual solvents, terpenes, and potency to guarantee less than 0.3 percent THC (tetrahydrocannabinol, the chemical compound in cannabis responsible for a euphoric high) is present.

Regulations

Federally legal under the 2014 Farm Bill, CBD from Hemp Oil is a rapid growth market across the USA. When derived from marijuana, CBD remains a schedule one controlled substances, giving hemp derived CBD oil infused products a competitive advantage on regulations. On June 28, 2018, the U.S. Senate passed the Agriculture Improvement Act of 2018 (i.e. the “Farm Bill), lifting the USA Industrial Hemp laws to an agricultural commodity status and effectively removed hemp from the controlled substance list.

Earlier this year, another milestone court ruling also provided significant regulatory support for the US CBD-Hemp sector. In February 2018, the Supreme Court preceded over the HIA (Hemp Industry Association) vs. DEA (Drug Enforcement Agency) in a class-action suit concerning the issue of CBD extracted from hemp, and the legality of industrial hemp. In the final ruling the Supreme Court unequivocally determined that – when produced domestically under the Farm Bill – hemp (and its derivatives) are not a controlled substance.

The Supreme Court ruling also found the Farm Bill (as it relates to hemp) “pre-empts” the Controlled Substances Act. Congress has since exempted Farm Bill hemp from the Controlled Substances Act (CSA) giving the Farm Bill primary jurisdiction over the governance of the CBD-Hemp Oil industry in the USA.

The DEA further conceded it does not “seek to control cannabinoids,” and that only marijuana derived cannabinoids are governed under the Controlled Substances Act. In May of 2018, the DEA issued a formal directive to all federal agencies (e.g. US Customs and Border Patrol) stating that cannabinoids are not controlled substances unless derived from marijuana, and that the “mere presence of cannabinoids” in any product or derivative does not render it a controlled substance. The Supreme Court ruling also resulted in the mediation of a settlement in what is now the third successful HIA vs. DEA suit in over a decade.

In Canada, the Senate approval of Bill C-45 legalized the production, distribution and use of recreation cannabis – with edibles to be added in 2019. The bill will officially become law as of October 17, 2018, creating a legal framework for the production, distribution, sale and possession of cannabis across Canada including cannabinoid-infused beverages.

3 Wholly Owned Subsidiaries

  • Phivida Organics Inc. offers professional-grade, wholesale, whole plant hemp oil extracts made from 100-percent certified organic hemp stalk. Phivida’s hemp oil extracts are CO2-extracted under quality assurance/clinical standards and are third-party lab tested to assure only pharmaceutical grade, cGMP certified, full-spectrum products are produced and available for sale. Phivida Organics produces hemp oil extracts that deliver nano-encapsulated cannabinoids in water soluble formulations designed to be absorbed up to 10 times faster than other oils, providing up to 400 percent bioavailability. Phivida Hemp Oil Vida+ extract products are available now online at www.Phivida.com.
  • Phivida Nutrition blends the best of nature into CBD-infused lifestyle branded beverages including a variety of CBD infused iced teas and CBD infused flavored waters.
  • Phivida Enhanced – Under the VIDA brand, CBD-infused tinctures, capsules and other supplement products are distributed to alternative health care clinics across the USA.

WeedMD-Phivida

Phivida has signed a binding letter of intent to joint venture WeedMD Inc. (TSX-V: WMD) (OTC:WDDMF) (FSE:4WE), a Health Canada federally licensed producer and distributor of medical cannabis, to form a joint venture focused on cannabis-infused beverages. The new joint-venture company, Cannabis Beverages Inc. (“CanBev”), plans to develop a production facility at WeedMD’s state-of-the-art greenhouse facility in Strathroy, Ontario, Canada. CanBev is on track to build and operate the first cannabis-infused beverage production facilities in Canada. The joint venture will focus on manufacturing, marketing and distribution of cannabinoid-infused beverages for the legalized medical and adult-use cannabis markets.

Management from both WeedMD and Phivida are collaborating on design and engineering strategies and site evaluations on a 610,000-square-foot, state-of-the art facility in Strathroy for the development of CanBev. As an emerging certified food grade production plant, the Strathroy facility is an ideal location and comes is equipped with extensive production infrastructure, including 50,000 sq. ft. of food production and packaging area, cold storage, loading docks, and adequate space to expand for future growth.

Strategic Agreements

Phivida Organics has also entered into an agreement to carry out a pharmacokinetic (PK) study on its hemp-derived, nanoencapsulated CBD with Artelo Biosciences Inc. at the University of Nottingham, School of Medicine at the Royal Derby Hospital, England. The study will test encapsulated-CBD on healthy volunteers and measure how fast and how much CBD enters the blood stream after oral consumption with each of the different formulations developed by Phivida Organics.

Phivida has also activated distribution agreements with Asayake Inc. to become one of the first federally approved CBD-infused food and supplement brands in Japan. With first mover status achieved, Phivida now markets to an underserved, yet highly informed population of 127 million patients and practitioners. The supplement market in Japan is estimated at US$10 billion with the overall functional foods market at US$21 billion. The Asia-Pacific region is the fastest growing market for natural plant-based supplements. Phivida now plans to prepare a formal application to Japan’s Consumer Affairs Agency to register the company’s CBD-infused functional food and beverage products for approval under the country’s Food with Functional Claims regime. The functional beverage market in Japan is estimated at US$10.35 billion with a CAGR of 2.5 percent (2015-2025).

Further Information

www.Phivida.com
+1 (844) 744-6646 (ext. #2)
IR@Phivida.com

Phivida Holdings Inc. (PHVAF), closed the day's trading session at $0.8722, off by 1.40%, on 72,764 volume with 61 trades. The average volume for the last 3 months is 88,998 and the stock's 52-week low/high is $0.05/$1.80.

Recent News

chart

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF), the largest private owner of lithium-rich land in Chile, is deep into an aggressive multi-project drill program that, to date, has provided encouraging results from sampling tests. The company’s efforts at its wholly owned Ollague project, located in the Antofagasta Region of Chile, are being rewarded, according to a recent news release (http://nnw.fm/YZ0oI).

Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.55082, off by 1.45%, on 65,865 volume with 27 trades. The average volume for the last 3 months is 50,822 and the stock's 52-week low/high is $0.535/$0.97.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences Inc.’s (OTCQB: PBIO) high pressure instruments, processing methods and platform technologies were prominently featured at the recent annual meeting of the Institute of Food Technologists (IFT) in Chicago, Illinois. In particular, attendees learned of PBI’s collaborative program with the Ohio State University's College of Food, Agricultural, and Environmental Sciences, a program funded by the U.S. Department of Agriculture (http://nnw.fm/14yqP). Also today, NetworkNewsWire released a report on the company detailing how PBIO was recently granted another patent to add to its intellectual property (“IP”) portfolio regarding its development of an automated “hands-free” sample handling for the next generation of the company’s high-pressure sample preparation platform systems. To view the full article, visit: http://nnw.fm/efN9F.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.70, off by 1.33%, on 201 volume with 3 trades. The average volume for the last 3 months is 1,878 and the stock's 52-week low/high is $2.70/$5.00.

Recent News

chart

Zenosense, Inc. (ZENO)

The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO).

Healthcare technology company Zenosense (OTC: ZENO), a co-owner of the United Kingdom’s MIDS Medical Limited (“MML”) and its innovative handheld MIDS technology, is engaged in the ongoing development of its innovative MIDS Cardiac device. A recent article about the company reads: “MIDS Cardiac aims is to deliver true laboratory accuracy, performing high-sensitivity troponin tests in the emergency room or out in the field to better identify if a patient with chest pain or shortness of breath is experiencing a myocardial infarction. To view the full article, visit: http://nnw.fm/69ZLf.

Zenosense, Inc. (ZENO) (the “Company”) is a healthcare technology developer that participates in transformational, disruptive medical diagnostic projects; particularly handheld devices used at the Point of Care which are displacing slow and expensive laboratory tests.

Zenosense is primarily focused on the development and commercialization of MIDS Cardiac™ through the Company’s joint venture ownership in MIDS Medical Limited (“MML”). MIDS Cardiac is in development as a cost-effective, handheld Point of Care (“POC”) diagnostic device and disposable test strip for the early, rapid detection of suspected acute myocardial infarction (“AMI”, or “heart attack”).

Identification of very low levels of cardiac markers can significantly accelerate critical triage, diagnosis, treatment and disposition of patients reporting chest pain. Cardiac troponin is well documented as the preferred biomarker for diagnosis of AMI, with evidence continuing to demonstrate that high sensitivity troponin is the most powerful prognostic biomarker for the assessment of cardiovascular risk in the general population. However, highly sensitive troponin assays are currently available only on state of the art, central laboratory analyzers. These analyzers are extremely expensive, not generally available at the POC and slow to turnaround results (typically 60 minutes) when time is critical.

True, high-sensitivity devices are not available in smaller handheld devices at the POC, where they are most needed. This is because the optical detection systems generally used in central laboratory analyzers cannot be effectively miniaturized.

MIDS Cardiac uses the patented MIDS technology platform, exclusively available to MML. Instead of using conventional optical detection, MIDS can detect and quantify assay beads nano-magnetically. This means it can be incorporated in a small device expected to achieve highly sensitive detection levels, which can support true high sensitivity cardiac biomarker tests in emergency settings, at the POC.

Harnessing world-class expertise, the MML laboratory is located at the prestigious Sci-Tech Daresbury campus in the U.K., internationally recognized for leading-edge, scientific research and commercial development. MML has the sole rights to the MIDS technology platform, which is protected by patent applications already granted in China and the USA, and applications now in the national phase in all other key geographic areas.

MIDS Cardiac aims to provide a single troponin I or T test within 3 minutes and three panel assay (additional cardiac biomarkers) on a disposable test strip within 8 minutes, using a hand-held device costing a fraction of the price of laboratory analyzers.

MIDS Cardiac should only require a pin prick of blood for a single assay test carried out on an easy-to-use, disposable microfluidic test strip. MIDS Cardiac is being designed to be operated quickly by minimally trained personnel, producing a simple to interpret result in emergency settings, even in the back of an ambulance.

Initial testing of the electronic and microfluidic components of the MIDS Cardiac “Hybrid Strip” system was completed in November 2017. The Hybrid Strip system used for development testing aims to replicate as closely as possible a fully integrated Lab on Chip MIDS test strip set-up. Development testing was conducted on both the assembled hybrid unit and its electronic and microfluidic components separately, focusing mainly on the electronics of the magnetic sensing system.

Testing revealed that a variety of brands and sizes of commercially available assay beads could be magnetically detected in very low quantities, including samples of beads that were previously undetectable. In several instances, the current “limit of detection” appeared to already be at or near to the range advised by MML’s assay consultants as suitable for a high sensitivity troponin assay.

Dr. Nasser Djennati, MML’s Managing Director and Chief Scientific Officer, said; “These results come in at the very high end of detection expectations, even at this Hybrid Strip stage. As we move forward into true Lab on Chip construction, I expect detection levels to improve further still.”

Cardiovascular disease is the leading cause of death in the western world, accounting for more than 17 million deaths in Europe and the United States alone. Nearly 20 million patients each year visit an emergency room with reports of chest pain, with hundreds of millions spent on unnecessary admissions to the hospital. Zenosense Inc. is confident MIDS Cardiac will deliver unparalleled levels of accuracy, speed, reliability, ease of use and cost savings, making it the future device of choice for hospitals, emergency rooms, medical practitioners, paramedics and in low-resource settings.

The MIDS technology is also seen as having a far wider application, with the platform being capable of performing Point of Care immunoassay tests for a vast array of common healthcare concerns, a market projected to be worth $23.7 billion per year worldwide by 2019. The medical testing market as a whole is projected to be worth $53.34 billion by 2021. Zenosense believes the MIDS technology could be the most significant advance in diagnostic testing services in decades.

Zenosense, Inc. (ZENO), closed the day's trading session at $0.32, up 2.40%, on 49,932 volume with 30 trades. The average volume for the last 3 months is 95,090 and the stock's 52-week low/high is $0.15/$0.895.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) was a featured company on this week’s episode of MoneyTV with Donald Baillargeon. MoneyTV is an internationally syndicated television program discussing “money and what makes it happen.” To view the full interview, visit: http://nnw.fm/5R1Zp. To view the full press release, visit: http://nnw.fm/6sZAO. Also today, CryptoCurrencyWire released a report on the company detailing how SING is simplifying the oftentimes confusing financial nuances of owning, storing, sending and receiving bitcoin through its SingleCoin virtual wallet, now available for iOS and Android via the Apple App Store and Google Play. SinglePoint President Wil Ralston announced the launch of SingleCoin during an appearance on MoneyTV with Donald Baillargeon (http://ccw.fm/l8yMu).

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0365, off by 3.69%, on 12,061,123 volume with 560 trades. The average volume for the last 3 months is 3,857,001 and the stock's 52-week low/high is $0.0235/$0.133.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV: PQE; OTC: PQEFF; FSE: A2DYWC) today announced that management is scheduled to present at The MicroCap Conference in New York City. The conference is being held on October 1-2, 2018 at the JW Marriott Essex House.
Event: The MicroCap Conference
Date: Monday, October 1, 2018
Time: 9:00 am ET
Location: Track 4 at JW Marriott Essex House – 160 Central Park S, New York, NY

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $0.90, off by 9.37%, on 434,024 volume with 214 trades. The average volume for the last 3 months is 411,098 and the stock's 52-week low/high is $0.289/$1.889.

Recent News

chart

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com, Inc. (OTCQB: CIIX) CEO Warren Wang discussed his goals for their CBD business in China on MoneyTV with Donald Baillargeon https://vimeo.com/292236399. Also today, CannabisNewsWire released a report highlighting the company and discussing how the Board of Medical Marihuana Regulation in Michigan is considering allowing provisioning centers (medical marijuana dispensaries) to make home deliveries of medical cannabis to patients who request that service.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed the day's trading session at $0.645, off by 11.76%, on 814,782 volume with 448 trades. The average volume for the last 3 months is 364,218 and the stock's 52-week low/high is $0.365/$1.58.

Recent News

chart

Pacific Software, Inc. (PFSF)

The QualityStocks Daily Newsletter would like to spotlight Pacific Software, Inc. (PFSF).

Pacific Software (OTC: PFSF), an emerging development technology corporation, offers product tracking from farm to fare through its blockchain ecommerce trade platform which is currently under development. A recent article discussing the company reads: “The Hyperledger technology offers a number of advantages. Its consensus algorithm is Practical Byzantine Fault Tolerance (PBFT), not the Proof-of-Work (PoW) widely employed by cryptocurrencies.” To view the full article, visit: http://nnw.fm/qDsS6. Also today, CryptoCurrencyWire released a report on the company detailing how PFSF offers the prospect of supply chains with a level of transparency and integrity that is sorely lacking in current systems.

Pacific Software, Inc. (PFSF) is focused on the design, development, and distribution of Hyperledger blockchain technology solutions for application to the specific needs of agriculture, cannabis, and the opioid epidemic.

The basic requirements of the systems to be developed include high-throughput transaction processing, traceability or tracking, visibility or monitoring, and transparency throughout the supply and value chains for the stakeholders. The development of this architecture will serve as an online commercial portal to service Pacific Software’s B2B accounts in the sectors below.

Agriculture
For application of its Agri-blockchain based system, Pacific Software will target farm-to-consumer exports to increase transparency, combat theft and counterfeit products, and reduce the health risks associated with shipping “tainted” agricultural products to other countries.

Cannabis
Perceiving blockchain as an ideal mechanism for the complexities of the cannabis industry, Pacific Software will strive to improve the transparency, compliance, and efficiency of the “seed-to-sale” supply chain in states where the plant is legal.

Controlled Substances
With the misuse of opioids on the rise worldwide, Pacific Software aims to apply its blockchain-based system to track opioids from pharmaceutical production to consumers and attempt to identify “Bad Actors” in the supply chain and fight against the global epidemic.

Business Model
The portal will be structured in a B2B format where clients will pay the company transaction fees, royalties, cash, cash equivalents and other forms of compensation to utilize its Hyperledger blockchain applications for their business models.

As the company executes these strategies, each Hyperledger blockchain-based system designed may be organized separately in wholly owned subsidiaries. To enhance its portfolio of holdings, Pacific Software may consider investments in companies where selected markets have imminent profitable results, providing appreciable value for investors and shareholders.

Pacific Software, Inc. (PFSF), closed the day's trading session at $4.04, off by 23.05%, on 150 volume with 2 trades. The average volume for the last 3 months is 3 and the stock's 52-week low/high is $4.00/$5.25.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.